Rheumatology
A study examined the phenotypic differences in patients with IgG4-RD with and without hypocomplementemia.
The US FDA approved the application for for equecabtagene autoleucel for the treatment of lupus.
The role of dietary and lifestyle interventions in the management of rheumatic disease is poorly understood.
Dr. Mithu Maheswaranathan on a study that shows metformin is a promising complementary therapy for SLE.
Patients with genetic risk factors with long-term exposure had a significantly higher risk of developing SLE.
A study found an independent relationship between hypertension and osteoporosis.
Treatment with ixekizumab led to rapid improvements in joint, skin, and nail symptoms for patients with psoriatic arthritis.
A study assessed glucocorticoid regimens on renal response, infections, and mortality in patients with lupus nephritis.
Systemic lupus erythematosus may be related to a greater risk of pregnancy complications.
A study assessed factors associated with kidney involvement in patients with systemic lupus erythematosus.
A study of real-world treatment and outcomes associated with ixekizumab found favorable efficacy in patients.
The FDA has approved Cyltezo, for the treatment of chronic inflammatory diseases.
Advertisement
Expert Interviews in Rheumatology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
